Contact
searchSearch
HMP Global

Antibiotics Topic Center

Featured Article

Direct-Acting Oral Anticoagulant Combinations
04/10/2024
04/10/2024
Pharmacy Learning Network
News
Antibiotic Recalled
01/19/2023
Jolynn Tumolo
A prescription antibiotic used to treat tuberculosis is being recalled for failing to meet impurity/degradation specifications.
A prescription antibiotic used to treat tuberculosis is being recalled for failing to meet impurity/degradation specifications.
A prescription antibiotic used...
01/19/2023
Pharmacy Learning Network
News
Legislation to Fund Antibiotic Development for Superbugs Stirs Controversy
12/21/2022
Arthur Allen; Liz Szabo
The PASTEUR Act, which would provide $6 billion to pharmaceutical manufacturers to incentivize antibiotic development, has sparked support and criticism throughout the health care industry.
The PASTEUR Act, which would provide $6 billion to pharmaceutical manufacturers to incentivize antibiotic development, has sparked support and criticism throughout the health care industry.
The PASTEUR Act, which would...
12/21/2022
Pharmacy Learning Network
News
Assessing Antibiotic Exposure Among Patients Admitted to VA Skilled Nursing Facility
12/08/2022
Edan Stanley
“The implementation of an antimicrobial stewardship monitoring program within the long-term care setting could assist in maximizing therapy while reducing antibiotic exposure,” found researchers.
“The implementation of an antimicrobial stewardship monitoring program within the long-term care setting could assist in maximizing therapy while reducing antibiotic exposure,” found researchers.
“The implementation of an...
12/08/2022
Veterans Health Today
From Veterans Health Today
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
Fighting Endocarditis One Antibiotic at a Time
09/22/2022
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
Dr Jennings reviews guideline recommendations and new research into the use of antibiotics in patients who are about to undergo invasive dental procedures.
Dr Jennings reviews guideline recommendations and new research into the use of antibiotics in patients who are about to undergo invasive dental procedures.
Dr Jennings reviews guideline...
09/22/2022
Pharmacy Learning Network
News
Antibiotic Recalled Over Impurity Findings
02/26/2021
Ascend Laboratories is recalling nine lots of cephalexin for oral suspension because impurity results during testing were “at [the] higher side of the specification limit.”
Ascend Laboratories is recalling nine lots of cephalexin for oral suspension because impurity results during testing were “at [the] higher side of the specification limit.”
Ascend Laboratories is recalling...
02/26/2021
Pharmacy Learning Network
News
Children’s Hospitals Are Partly to Blame as Superbugs Increasingly Attack Kids
01/04/2021
A growing body of research shows that overuse and misuse of antibiotics in children’s hospitals is helping fuel superbugs, which typically strike frail older adults but are increasingly infecting kids—and the pandemic is making things worse.
A growing body of research shows that overuse and misuse of antibiotics in children’s hospitals is helping fuel superbugs, which typically strike frail older adults but are increasingly infecting kids—and the pandemic is making things worse.
A growing body of research shows...
01/04/2021
Pharmacy Learning Network
News
Antibiotic Tablets Recalled
06/03/2020
A Class II recall is active for a prescription antibiotic used to treat bacterial infections.
A Class II recall is active for a prescription antibiotic used to treat bacterial infections.
A Class II recall is active for...
06/03/2020
Pharmacy Learning Network
News
Antibiotic Recalled
03/27/2020
A prescription antibiotic used to treat a variety of bacterial infections, such as acne, urinary tract infections, and respiratory infections is being recalled.
A prescription antibiotic used to treat a variety of bacterial infections, such as acne, urinary tract infections, and respiratory infections is being recalled.
A prescription antibiotic used...
03/27/2020
Pharmacy Learning Network
News
Risk of Major Malformations Increased Among Pregnant Women Prescribed Macrolide Antibiotics
02/21/2020
During the first trimester of pregnancy, researchers found macrolide antibiotics increase the risk of major malformations, specifically cardiovascular malformations, compared with those who received penicillin antibiotics.
During the first trimester of pregnancy, researchers found macrolide antibiotics increase the risk of major malformations, specifically cardiovascular malformations, compared with those who received penicillin antibiotics.
During the first trimester of...
02/21/2020
Pharmacy Learning Network
News
Antibiotics Likely Unneeded for Aspiration of Pancreatic Cysts
02/03/2020
Although guidelines recommend antibiotic prophylaxis before or during endoscopic ultrasound-guided fine needle aspiration of pancreatic cysts, the risk of infection from the procedure is low, a randomized controlled trial reveals.
Although guidelines recommend antibiotic prophylaxis before or during endoscopic ultrasound-guided fine needle aspiration of pancreatic cysts, the risk of infection from the procedure is low, a randomized controlled trial reveals.
Although guidelines recommend...
02/03/2020
Pharmacy Learning Network

Newsfeed

News
Antibiotic Recalled
01/19/2023
Jolynn Tumolo
A prescription antibiotic used to treat tuberculosis is being recalled for failing to meet impurity/degradation specifications.
A prescription antibiotic used to treat tuberculosis is being recalled for failing to meet impurity/degradation specifications.
A prescription antibiotic used...
01/19/2023
Pharmacy Learning Network
News
Legislation to Fund Antibiotic Development for Superbugs Stirs Controversy
12/21/2022
Arthur Allen; Liz Szabo
The PASTEUR Act, which would provide $6 billion to pharmaceutical manufacturers to incentivize antibiotic development, has sparked support and criticism throughout the health care industry.
The PASTEUR Act, which would provide $6 billion to pharmaceutical manufacturers to incentivize antibiotic development, has sparked support and criticism throughout the health care industry.
The PASTEUR Act, which would...
12/21/2022
Pharmacy Learning Network
News
Assessing Antibiotic Exposure Among Patients Admitted to VA Skilled Nursing Facility
12/08/2022
Edan Stanley
“The implementation of an antimicrobial stewardship monitoring program within the long-term care setting could assist in maximizing therapy while reducing antibiotic exposure,” found researchers.
“The implementation of an antimicrobial stewardship monitoring program within the long-term care setting could assist in maximizing therapy while reducing antibiotic exposure,” found researchers.
“The implementation of an...
12/08/2022
Veterans Health Today
News
Antibiotics Overprescribed for COPD
10/22/2019
"A recent multicenter trial showed that antibiotic prescribing can be reduced safely in COPD patients by using a rapid diagnostic (C-reactive protein) test," study coauthor Laura Shallcross, PhD, University College London, explained.
"A recent multicenter trial showed that antibiotic prescribing can be reduced safely in COPD patients by using a rapid diagnostic (C-reactive protein) test," study coauthor Laura Shallcross, PhD, University College London, explained.
"A recent multicenter trial...
10/22/2019
Pharmacy Learning Network
News
Each Added Day of Postop Antibiotics Ups Risk of Kidney Injury, C. Diff Infection
05/01/2019
According to new study findings, each additional day of surgical antimicrobial prophylaxis increases the risks of acute kidney injury and Clostridium difficile infection and does not lead to reductions in surgical site infections.
According to new study findings, each additional day of surgical antimicrobial prophylaxis increases the risks of acute kidney injury and Clostridium difficile infection and does not lead to reductions in surgical site infections.
According to new study findings,...
05/01/2019
Pharmacy Learning Network
News
Antibiotic Prescriptions Often Exceed Recommended Treatment Durations
03/07/2019
Many antibiotic prescriptions for common infections in primary care exceed durations recommended by guidelines, according to a new study.
Many antibiotic prescriptions for common infections in primary care exceed durations recommended by guidelines, according to a new study.
Many antibiotic prescriptions...
03/07/2019
Pharmacy Learning Network
News
How Oral Antibiotics Impact Kidney Stone Risk
05/11/2018
A new study examined the risk of kidney stones in patients taking oral antibiotics. 
A new study examined the risk of kidney stones in patients taking oral antibiotics. 
A new study examined the risk...
05/11/2018
Pharmacy Learning Network
News
CDC Reports Rare, Antibiotic Resistant Bacteria in 27 States
04/05/2018
The CDC identified over 200 cases of bacteria with rare antibiotic resistance genes in 27 states during the first 9 months of 2017, according to a new report.
The CDC identified over 200 cases of bacteria with rare antibiotic resistance genes in 27 states during the first 9 months of 2017, according to a new report.
The CDC identified over...
04/05/2018
Pharmacy Learning Network
PharmLaw
Iowa Attorney General Accuses Insulin Makers and PBMs of Deceptive Pricing Practices
02/03/2026
Juliet Gallagher
Iowa Attorney General Brenna Bird has filed a sweeping lawsuit against major insulin manufacturers and pharmacy benefit managers (PBMs), alleging a coordinated, years-long scheme to artificially inflate the prices of insulin and other...
Iowa Attorney General Brenna Bird has filed a sweeping lawsuit against major insulin manufacturers and pharmacy benefit managers (PBMs), alleging a coordinated, years-long scheme to artificially inflate the prices of insulin and other...
Iowa Attorney General Brenna...
02/03/2026
Pharmacy Learning Network
News
Antacid Tablets Recalled Due to Failed Disintegration Specifications
01/29/2026
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class II recall for INON ACE Antacid Tablets due to failed disintegration specifications, which may reduce the product’s effectiveness in relieving indigestion and gas.
The US Food and Drug Administration (FDA) has issued a Class II recall for INON ACE Antacid Tablets due to failed disintegration specifications, which may reduce the product’s effectiveness in relieving indigestion and gas.
The US Food and Drug...
01/29/2026
Pharmacy Learning Network
News
Glycopyrrolate Oral Solution Recalled Due to Degradation Specification Failure
01/29/2026
Hannah Musick
A Class III recall has been issued for glycopyrrolate oral solution due to degradation/impurity specification failure.
A Class III recall has been issued for glycopyrrolate oral solution due to degradation/impurity specification failure.
A Class III recall has been...
01/29/2026
Pharmacy Learning Network
News
Icosapent Ethyl Capsules Under Class II Recall
01/29/2026
Hannah Musick
The US Food and Drug Administration (FDA) is monitoring a Class II recall of icosapent ethyl capsules after capsule leakage caused subpotency, potentially affecting cardiovascular risk reduction therapy in patients with elevated triglycerides.
The US Food and Drug Administration (FDA) is monitoring a Class II recall of icosapent ethyl capsules after capsule leakage caused subpotency, potentially affecting cardiovascular risk reduction therapy in patients with elevated triglycerides.
The US Food and Drug...
01/29/2026
Pharmacy Learning Network
PharmLaw
PCMA Sues California Over SB 41, Challenging PBM Fiduciary Duties Under ERISA
01/27/2026
Juliet Gallagher
California’s most ambitious pharmacy benefit manager (PBM) reform effort has drawn an immediate legal challenge, as the Pharmaceutical Care Management Association (PCMA) filed a federal lawsuit contesting key provisions of Senate Bill 41 (SB...
California’s most ambitious pharmacy benefit manager (PBM) reform effort has drawn an immediate legal challenge, as the Pharmaceutical Care Management Association (PCMA) filed a federal lawsuit contesting key provisions of Senate Bill 41 (SB...
California’s most ambitious...
01/27/2026
Pharmacy Learning Network
News
Recall Issued for Diclofenac Sodium Topical Gel Due to pH Specification Failure
01/22/2026
Grace Taylor, MS, MA
The US Food and Drug Administration (FDA) is overseeing a nationwide, voluntary Class III recall of diclofenac sodium topical gel 1% after the product failed to meet pH specifications, affecting more than 92 000 tubes distributed across the...
The US Food and Drug Administration (FDA) is overseeing a nationwide, voluntary Class III recall of diclofenac sodium topical gel 1% after the product failed to meet pH specifications, affecting more than 92 000 tubes distributed across the...
The US Food and Drug...
01/22/2026
Pharmacy Learning Network
News
Furosemide 40 mg Tablets Recalled Due to Foreign Substance Contamination
01/22/2026
Grace Taylor, MS, MA
The US Food and Drug Administration (FDA) is alerting pharmacists to a voluntary Class II nationwide recall of Furosemide 40 mg tablets after a foreign substance was detected in a distributed lot.
The US Food and Drug Administration (FDA) is alerting pharmacists to a voluntary Class II nationwide recall of Furosemide 40 mg tablets after a foreign substance was detected in a distributed lot.
The US Food and Drug...
01/22/2026
Pharmacy Learning Network
PharmLaw
Compounding Pharmacy Sues Eli Lilly, Novo Nordisk Over Alleged GLP-1 Antitrust Violations
01/21/2026
Juliet Gallagher
An Arizona-based compounding pharmacy has filed an antitrust lawsuit accusing Eli Lilly and Novo Nordisk of unlawfully restricting competition in the market for GLP-1 medications, escalating a legal battle over compounded versions of...
An Arizona-based compounding pharmacy has filed an antitrust lawsuit accusing Eli Lilly and Novo Nordisk of unlawfully restricting competition in the market for GLP-1 medications, escalating a legal battle over compounded versions of...
An Arizona-based compounding...
01/21/2026
Pharmacy Learning Network
News
Imprimis NJOF Initiates Class II Recall of Tri-Moxi+ Intraocular Injection Due to Particulate Matter
01/15/2026
Juliet Gallagher
Imprimis NJOF, LLC is recalling Tri-Moxi+® (Triamcinolone 9 mg/0.6 mL, Moxifloxacin 0.6 mg/0.6 mL) Single-Use Intraocular Injection, NDC 71384-746-06. The recall encompasses 314 boxes totaling 6280 pre-filled syringes. Affected product...
Imprimis NJOF, LLC is recalling Tri-Moxi+® (Triamcinolone 9 mg/0.6 mL, Moxifloxacin 0.6 mg/0.6 mL) Single-Use Intraocular Injection, NDC 71384-746-06. The recall encompasses 314 boxes totaling 6280 pre-filled syringes. Affected product...
Imprimis NJOF, LLC is recalling...
01/15/2026
Pharmacy Learning Network
News
FDA Reports Class II Recall of Imprimis Intraocular Dexamethasone Injections Due to Glass Particulates
01/15/2026
Juliet Gallagher
Imprimis NJOF, LLC is recalling two compounded intraocular injectable drug products distributed nationwide in the US. The first product, Dexamethasone Moxifloxacin Intraocular Injection (1 mg/mL and 5 mg/mL, 1 mL, Rx only; NDC 71384-512-0.1),...
Imprimis NJOF, LLC is recalling two compounded intraocular injectable drug products distributed nationwide in the US. The first product, Dexamethasone Moxifloxacin Intraocular Injection (1 mg/mL and 5 mg/mL, 1 mL, Rx only; NDC 71384-512-0.1),...
Imprimis NJOF, LLC is recalling...
01/15/2026
Pharmacy Learning Network

Insights

Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
Fighting Endocarditis One Antibiotic at a Time
09/22/2022
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
Dr Jennings reviews guideline recommendations and new research into the use of antibiotics in patients who are about to undergo invasive dental procedures.
Dr Jennings reviews guideline recommendations and new research into the use of antibiotics in patients who are about to undergo invasive dental procedures.
Dr Jennings reviews guideline...
09/22/2022
Pharmacy Learning Network

Interactive Features

Subscribe Today

Pharmacy Learning Network Newsletter

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use